Evolus Inc (EOLS)
13.70
+0.46
(+3.47%)
USD |
NASDAQ |
May 16, 16:00
13.70
0.00 (0.00%)
After-Hours: 20:00
Evolus Cash from Investing (TTM): -1.913M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.913M |
| December 31, 2023 | -1.627M |
| September 30, 2023 | -2.657M |
| June 30, 2023 | -3.017M |
| March 31, 2023 | -3.189M |
| December 31, 2022 | -2.939M |
| September 30, 2022 | -1.938M |
| June 30, 2022 | -1.018M |
| March 31, 2022 | -1.016M |
| December 31, 2021 | 4.03M |
| September 30, 2021 | 24.12M |
| June 30, 2021 | 53.40M |
| Date | Value |
|---|---|
| March 31, 2021 | 63.17M |
| December 31, 2020 | 12.19M |
| September 30, 2020 | 6.467M |
| June 30, 2020 | 11.56M |
| March 31, 2020 | 10.40M |
| December 31, 2019 | -23.43M |
| September 30, 2019 | -37.41M |
| June 30, 2019 | -71.80M |
| March 31, 2019 | -80.03M |
| December 31, 2018 | -0.009M |
| September 30, 2018 | -0.009M |
| June 30, 2018 | -0.009M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-71.80M
Minimum
Jun 2019
63.17M
Maximum
Mar 2021
1.669M
Average
-1.322M
Median
Cash from Investing (TTM) Benchmarks
| Viatris Inc | -168.90M |
| Shockwave Medical Inc | -716.36M |
| Perspective Therapeutics Inc | 24.37M |
| Electromed Inc | -0.79M |
| Xtant Medical Holdings Inc | -24.78M |